Published in J Exp Med on September 01, 1981
Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest (1998) 2.60
Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi. Proc Natl Acad Sci U S A (1983) 2.17
Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype. J Exp Med (1983) 2.15
Purification and partial sequence analysis of human T-cell growth factor. Proc Natl Acad Sci U S A (1983) 2.09
A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J Exp Med (1984) 2.06
Deletion of potentially self-reactive T cell receptor specificities in L3T4-, Lyt-2- T cells of lpr mice. J Exp Med (1988) 1.69
Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol (1985) 1.61
Association of lpr gene with graft-vs.-host disease-like syndrome. J Exp Med (1985) 1.56
A new allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse. J Exp Med (1990) 1.48
Two types of potassium channels in murine T lymphocytes. J Gen Physiol (1987) 1.48
Deficit of interleukin 2 production associated with impaired T-cell proliferative responses in Mycobacterium lepraemurium infection. Infect Immun (1983) 1.42
Selectivity and gating of the type L potassium channel in mouse lymphocytes. J Gen Physiol (1991) 1.35
A polymorphic microsatellite in the tumor necrosis factor alpha promoter identifies an allele unique to the NZW mouse strain. J Exp Med (1990) 1.31
IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice. Clin Immunol (2008) 1.24
Immunologic abnormalities of mice bearing the gld mutation suggest a common pathway for murine nonmalignant lymphoproliferative disorders with autoimmunity. Proc Natl Acad Sci U S A (1985) 1.24
Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy. J Biomed Biotechnol (2010) 1.16
Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice. A histologic and immunocytochemical analysis. Am J Pathol (1987) 1.16
Inflammatory cytokines in systemic lupus erythematosus. J Biomed Biotechnol (2011) 1.16
Defect in negative selection in lpr donor-derived T cells differentiating in non-lpr host thymus. J Exp Med (1991) 1.16
The dysregulation of cytokine networks in systemic lupus erythematosus. J Interferon Cytokine Res (2011) 1.14
Amino acid sequence and post-translational modification of human interleukin 2. Proc Natl Acad Sci U S A (1984) 1.13
The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity. J Biomed Biotechnol (2010) 1.13
Influence of early or late dietary restriction on life span and immunological parameters in MRL/Mp-lpr/lpr mice. Proc Natl Acad Sci U S A (1984) 1.12
Immune dysfunction in diabetes-prone BB rats. Interleukin 2 production and other mitogen-induced responses are suppressed by activated macrophages. J Exp Med (1984) 1.10
Tumour necrosis factor and other cytokines in murine lupus. Ann Rheum Dis (1999) 1.09
Autoimmune diseases: immunopathology and etiopathogenesis. Am J Pathol (1982) 1.07
Monocytosis in the BXSB model for systemic lupus erythematosus. J Exp Med (1984) 1.07
Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus. J Clin Invest (1995) 1.06
Inhibition by restricted-calorie diet of lymphoproliferative disease and renal damage in MRL/lpr mice. Proc Natl Acad Sci U S A (1984) 1.02
Spontaneous recovery of the decreased expression in vitro of interleukin 2 receptors in rheumatoid arthritis. Clin Exp Immunol (1988) 1.00
Antibodies of predetermined specificity against chemically synthesized peptides of human interleukin 2. Proc Natl Acad Sci U S A (1984) 0.98
Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin Exp Immunol (2008) 0.98
T-cell antigen-receptor genes in autoimmune mice. Proc Natl Acad Sci U S A (1986) 0.98
Calcium/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus. J Immunol (2012) 0.97
The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus. J Biomed Biotechnol (2011) 0.97
Dietary fat influences the expression of autoimmune disease in MRL/lpr/lpr mice. Immunology (1986) 0.97
Unusual cell surface properties of the T lymphocyte population expanding in MRL/Mp-lpr/lpr mice. Immunology (1982) 0.96
The role of vascular smooth muscle cells in experimental autoimmune vasculitis. I. The initiation of delayed type hypersensitivity angiitis. Am J Pathol (1984) 0.95
Functional heterogeneity of L3T4+ T cells in MRL-lpr/lpr mice. L3T4+ T cells suppress major histocompatibility complex-self-restricted L3T4+ T helper cell function in association with autoimmunity. J Exp Med (1988) 0.95
Abnormalities induced by the mutant gene, lpr. Patterns of disease and expression of murine leukemia viruses in SJL/J mice homozygous and heterozygous for lpr. J Exp Med (1985) 0.95
T cells as a therapeutic target in SLE. Lupus (2015) 0.94
Local therapy of cancer with free IL-2. Cancer Immunol Immunother (2008) 0.93
Lack of coreceptor allows survival of chronically stimulated double-negative alpha/beta T cells: implications for autoimmunity. J Exp Med (2001) 0.93
Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice. Clin Exp Immunol (1999) 0.92
Interleukin-2 treatment reverses effects of cAMP-responsive element modulator α-over-expressing T cells in autoimmune-prone mice. Clin Exp Immunol (2015) 0.88
Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome. Clin Exp Immunol (1986) 0.88
Analysis of restriction fragment length polymorphism in lymphokine genes of normal and autoimmune mice. J Exp Med (1989) 0.88
Enhanced interferon-gamma (IFN) production by lymph node cells from autoimmune (MRL/1, MRL/n) mice. Clin Exp Immunol (1989) 0.86
Delineation of two defects responsible for T-cell hyporesponsiveness to concanavalin A in MRL congenic mice. Immunology (1986) 0.86
High hepatic natural killer cell activity in murine lupus. J Exp Med (1987) 0.86
Incorporation, distribution, and turnover of arachidonic acid within membrane phospholipids of B220+ T cells from autoimmune-prone MRL-lpr/lpr mice. J Exp Med (1990) 0.84
T cell function in systemic lupus erythematosus: normal production of and responsiveness to interleukin 2. Clin Exp Immunol (1986) 0.84
Longevity of SLE-prone mice increased by dietary 2-mercaptoethanol via a mechanism imprinted within the first 28 days of life. Virulence (2010) 0.83
The effects of CP 17193, an immunosuppressive pyrazaloquinoline, on the development of spontaneous lupus disease in NZBW F1 hybrid mice. Clin Exp Immunol (1992) 0.82
Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis. Immunology (1995) 0.82
Low-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunity. Int J Mol Sci (2014) 0.81
The role of autoreactive T-cell hybridomas from autoimmune model mice. Immunology (1988) 0.81
[Regulatory T‑cells in systemic lupus erythematosus : IL-2 is decisive for loss of tolerance]. Z Rheumatol (2016) 0.80
The effect of the immunomodulator agent AS101 on interleukin-2 production in systemic lupus erythematosus (SLE) induced in mice by a pathogenic anti-DNA antibody. Clin Exp Immunol (1990) 0.80
Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr mice. Immunology (2000) 0.80
Defective signal-transduction pathways in T-cells from autoimmune MRL-lpr/lpr mice are associated with increased polyamine concentrations. Biochem J (1995) 0.80
Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupus. Autoimmunity (2010) 0.79
Synergistic induction by calcium ionophore and phorbol ester of interleukin-2 (IL-2) receptor expression, IL-2 production, and proliferation in autoimmune MRL/MP-lpr mice. Immunology (1986) 0.79
Changes in the cytokine profile of lupus-prone mice (NZB/NZW)F1 induced by Plasmodium chabaudi and their implications in the reversal of clinical symptoms. Clin Exp Immunol (2000) 0.79
Analysis of defective delayed-type hypersensitivity in autoimmune mice bearing lpr gene. Clin Exp Immunol (1986) 0.79
B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus. J Neuroinflammation (2016) 0.77
Distinct p21 requirements for regulating normal and self-reactive T cells through IFN-γ production. Sci Rep (2015) 0.77
Inhibition of lymphoproliferation and protein kinase C by synthetic peptides with sequence identity to the transmembrane and Q proteins of visna virus. J Virol (1990) 0.77
Maternal microchimerism leads to the presence of interleukin-2 in interleukin-2 knock out mice: implications for the role of interleukin-2 in thymic function. Cell Immunol (2007) 0.77
Dysregulation of T lymphocyte proliferative responses in autoimmunity. PLoS One (2014) 0.77
Inosine monophosphate dehydrogenase (IMPDH) inhibition in vitro suppresses lymphocyte proliferation and the production of immunoglobulins, autoantibodies and cytokines in splenocytes from MRLlpr/lpr mice. Clin Exp Immunol (2001) 0.77
Analysis of B-cell abnormalities in autoimmune mice by in vitro culture system using two types of bone marrow stromal cell clone. Immunology (1990) 0.77
B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1994) 0.76
Relationship of macrophages to defective delayed-type hypersensitivity in B6/lpr mice. Clin Exp Immunol (1986) 0.75
Interleukin 2 production in a family with systemic lupus erythematosus and a C4Q0 heterozygous inheritance. Ann Rheum Dis (1991) 0.75
Antigen-specific T-cell hyporesponsiveness in MRL congenic mice can be explained by two independent cellular defects. Immunology (1987) 0.75
Functional consequences of perceived interleukin deficiencies? Analysis employing NZB x C58 recombinant inbred mice. Clin Exp Immunol (1985) 0.75
Interleukin-2 production in Brown-Norway rats with HgCl2-induced autoimmune disease: paradoxical in vivo versus in vitro findings. Clin Exp Immunol (1988) 0.75
Migration of carbon-laden peritoneal macrophages into the thymus of autoimmune New Zealand mice. J Anat (1989) 0.75
Amplifier T cell activity is decreased in MRL/1 mice: failure of concanavalin A and anti-lymphocyte serum to enhance antibody responses to thymus-independent antigens. Clin Exp Immunol (1985) 0.75
Reversible interleukin-2 response defects in systemic lupus erythematosus. Clin Exp Immunol (1989) 0.75
Defective LN cell proliferative response to Sm antigen in mice bearing the lpr gene. Clin Exp Immunol (1984) 0.75
C-myc expression in lymphocytes of MRL/MP-lpr mice activated by A23187 and TPA. Immunology (1988) 0.75
CD74 Deficiency Mitigates Systemic Lupus Erythematosus-like Autoimmunity and Pathological Findings in Mice. J Immunol (2017) 0.75
Expression of an EL4 tumour-associated determinant on subpopulations of murine T cells in normal and lympho-proliferative autoimmune mice. Immunology (1991) 0.75
Subpopulations of CD4+ cells in lpr/lpr mice: differences in expression of T cell receptor/CD3 complex and proliferative responses. Clin Exp Immunol (1990) 0.75
T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol (1978) 28.92
Long term culture of tumour-specific cytotoxic T cells. Nature (1977) 14.15
Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity. J Exp Med (1975) 13.69
T-cell growth factor. Immunol Rev (1980) 8.11
Immune responses in vitro. I. Culture conditions for antibody synthesis. Cell Immunol (1972) 6.04
The functional relationship of the interleukins. J Exp Med (1980) 5.62
Etiopathogenesis of murine SLE. Immunol Rev (1981) 4.39
Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J Exp Med (1980) 4.32
Ligand-activated T cell growth factor-induced proliferation: absorption of T cell growth factor by activated T cells. J Immunol (1979) 3.37
Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors. J Exp Med (1977) 3.30
Generation of cytolytic T lymphocytes in vitro. IX. induction of secondary CTL responses in primary long-term MLC by supernatants from secondary MLC. J Immunol (1978) 2.65
Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes. J Exp Med (1979) 2.55
Interleukin 2: a class of T cell growth factors. Immunol Rev (1980) 2.21
Studies on T lymphocyte activation II. The target cells for concanavalin A-induced growth factors. Eur J Immunol (1979) 2.10
Limiting dilution analysis of alloantigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses. J Immunol (1979) 1.82
Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells. J Exp Med (1974) 1.77
Soluble factors substitute for T-T-cell collaboration in generation of T-killer lymphocytes. Nature (1976) 1.69
Quantitative studies on the precursors of cytotoxic lymphocytes. I. Characterization of a clonal assay and determination of the size of clones derived from single precursors. J Immunol (1977) 1.57
Flow cytometry analysis of T cells and continuous T-cell lines from autoimmune MRL/l mice. Nature (1981) 1.56
In vitro generation of suppressor cell activity: suppression of in vitro induction if cell-mediated cytotoxicity. J Immunol (1976) 1.55
TCGF production for cloning and growth of functional human T lymphocytes. Scand J Immunol (1980) 1.50
Potentiation of the T lymphocyte response to mitogens. III. Properties of the mediator(s) from adherent cells. Cell Immunol (1974) 1.49
Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses. J Immunol (1980) 1.48
Patterns of immune reactivity in autoimmune murine strains. I. Cell-mediated immune responses induced by H-2 indentical and H-2 incompatible stimulator cells. J Immunol (1979) 1.43
Splenic T-killer cells can be generated by allogeneic thymic cells in conjunction with assisting factor. Nature (1977) 1.32
Cell-free media of mixed lymphocyte cultures augmenting sensitization in vitro of mouse T lymphocytes against allogeneic fibroblasts. Eur J Immunol (1976) 1.22
Revised nomenclature for antigen-nonspecific T cell proliferation and helper factors. J Immunol (1979) 1.18
Generation of effector cells from T cell subsets. II. Lyt 123 T cells contain the precursors for all primary cytotoxic effector cells and for cells involved in the regulation of cytotoxic responses. Eur J Immunol (1980) 1.13
Natural thymocytotoxic autoantibodies in autoimmune and normal mice. J Immunol (1979) 1.08
T and B lymphocytes in New Zealand black mice. An analysis of the theta, TL and MBLA markers. Clin Exp Immunol (1972) 1.03
Lymphocyte classes in New Zealand mice. I. Ontogeny and mitogen responsiveness of thymocytes and thymus-derived lymphocytes. J Immunol (1972) 1.03
Specificities of NZB anti-H-2d CML reactions: role of Qa-1 and retroviral gp70 antigens. J Immunol (1981) 0.92
In vitro sensitization of thymocytes. Role of H-21 I region determinants and cell-free mixed leukocyte culture supernates in generation of cytotoxic responses. J Exp Med (1978) 0.87
Association of defective feedback suppressor T cell activity with autoimmunity in NZB mice. Arthritis Rheum (1978) 0.86
T cell-mediated immune responses of lupus-prone BXSB mice and other murine strains. Clin Exp Immunol (1979) 0.83
A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol (1966) 43.66
Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med (1978) 11.99
Murine models of systemic lupus erythematosus. Adv Immunol (1985) 9.79
The regulatory influence of activated T cells on B cell responses to antigen. Adv Immunol (1972) 9.43
Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med (1968) 8.91
The Raji cell radioimmune assay for detecting immune complexes in human sera. J Clin Invest (1976) 8.06
Cell interactions between histoincompatible T and B lymphocytes. VII. Cooperative responses between lymphocytes are controlled by genes in the I region of the H-2 complex. J Exp Med (1975) 7.64
The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med (1967) 6.81
Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol (1980) 6.69
Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice. J Exp Med (1969) 6.03
The function and interrelationships of T-cell receptors, Ir genes and other histocompatibility gene products. Transplant Rev (1975) 5.88
Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization. J Exp Med (1970) 5.71
Critical role of determinant presentation in the induction of specific responses in immunocompetent lymphocytes. J Exp Med (1973) 5.30
The allogeneic effect on immune responses: model for regulatory influences of T lymphocytes on the immune system. Transplant Rev (1972) 5.23
New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates. Biochemistry (1979) 5.02
Autologous immune complex nephritis induced with renal tubular antigen. I. Identification and isolation of the pathogenetic antigen. J Exp Med (1968) 4.79
The allogeneic effect in inbred mice. II. Establishment of the cellular interactions required for enhancement of antibody production by the graft-versus-host reaction. J Exp Med (1972) 4.70
Etiopathogenesis of murine SLE. Immunol Rev (1981) 4.39
Carrier function in anti-hapten antibody responses. 3. Stimulation of antibody synthesis and facilitation of hapten-specific secondary antibody responses by graft-versus-host reactions. J Exp Med (1971) 4.29
Cell interactions between histoincompatible T and B lymphocytes. The H-2 gene complex determines successful physiologic lymphocyte interactions. Proc Natl Acad Sci U S A (1973) 4.12
Cell interactions between histoincompatible T and B lymphocytes. IV. Involvement of the immune response (Ir) gene in the control of lymphocyte interactions in responses controlled by the gene. J Exp Med (1973) 4.05
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Lymphocytic choriomeningitis: production of antibody by "tolerant" infected mice. Science (1967) 4.01
Autologous immune-complex pathogenesis of experimental allergic glomerulonephritis. Science (1967) 3.96
Circulating immune complexes in the idiopathic interstitial pneumonias. N Engl J Med (1978) 3.83
Experimental glomerulonephritis: immunological events and pathogenetic mechanisms. Adv Immunol (1967) 3.83
Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease. J Immunol (1978) 3.78
Serum transfer of collagen-induced arthritis in mice. J Exp Med (1983) 3.74
The pathogenesis of glomerulonephritis. Am J Med (1968) 3.61
Presence of anti-Sm reactivity in autoimmune mouse strains. J Exp Med (1978) 3.58
Activation of T and B lymphocytes in vitro. II. Biological and biochemical properties of an allogeneic effect factor (AEF) active in triggering specific B lymphocytes. J Exp Med (1974) 3.54
Endogenous oncornaviral gene expression in adult and fetal mice: quantitative, histologic, and physiologic studies of the major viral glycorprotein, gp70. J Exp Med (1976) 3.51
Autologous immune complex nephritis induced with renal tubular antigen. II. The pathogenetic mechanism. J Exp Med (1968) 3.40
The effect of passively administered antibody on antibody synthesis. J Exp Med (1967) 3.31
A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys (1994) 3.29
Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor. J Exp Med (1974) 3.29
Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell (1992) 3.24
T cell antigen receptor-mediated activation of phospholipase C requires tyrosine phosphorylation. Science (1990) 3.23
Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int (1973) 3.09
The biology and detection of immune complexes. Adv Immunol (1979) 3.05
Prostaglandin E-1: a potential mediator of the inflammatory response. Ann N Y Acad Sci (1971) 2.94
Activation of T and B lymphocytes in vitro. I. Regulatory influence of bacterial lipopolysaccharide (LPS) on specific T-cell helper function. J Exp Med (1974) 2.90
IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides. J Immunol (1979) 2.86
Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. J Exp Med (1979) 2.86
A spontaneous rheumatoid arthritis-like disease in MRL/l mice. J Exp Med (1982) 2.76
Rapid activation of the T-cell tyrosine protein kinase pp56lck by the CD45 phosphotyrosine phosphatase. Proc Natl Acad Sci U S A (1989) 2.70
The histocompatibility-linked immune response genes. Adv Cancer Res (1975) 2.64
The potential pathogenic role of complement in dengue hemorrhagic shock syndrome. N Engl J Med (1973) 2.64
Mechanism and modification of rejection of heterografts between divergent species. Transplant Proc (1970) 2.63
Macrophage-activating factor produced by a T cell hybridoma: physiochemical and biosynthetic resemblance to gamma-interferon. J Immunol (1983) 2.61
Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest (1998) 2.60
Distribution of lymphocytes identified by surface markers in murine strains with systemic lupus erythematosus-like syndromes. J Exp Med (1979) 2.55
Carrier function in anti-hapten immune responses. II. Specific properties of carrier cells capable of enhancing anti-hapten antibody responses. J Exp Med (1970) 2.54
The antibody response of mice to murine leukemia virus in spontaneous infection: absence of classical immunologic tolerance (AKR mice-complement-fixing antibodies-lymphocytic choriomeningitis virus-immunofluorescence-glomerular deposits of antigen-antibody complexes). Proc Natl Acad Sci U S A (1972) 2.54
Binding of soluble immune complexes to human lymphoblastoid cells. II. Use of Raji cells to detect circulating immune complexes in animal and human sera. J Exp Med (1974) 2.51
Cell interactions between histoincompatible T and B lymphocytes. I. Allogeneic effect by irradiated host T cells on adoptively transferred histoincompatible B lymphocytes. J Exp Med (1973) 2.49
IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis. Arthritis Rheum (1974) 2.45
Transfer of ovine experimental allergic glomerulonephritis (EAG) with serum. J Exp Med (1966) 2.42
Histocompatibility-linked genetic control of disease susceptibility. Murine lymphocytic choriomeningitis virus infection. J Exp Med (1973) 2.39
Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients. Surgery (1970) 2.38
The oncornavirus glycoprotein gp69/71: a constituent of the surface of normal and malignant thymocytes. J Exp Med (1975) 2.37
Radioresistance of carrier-specific helper thymus-derived lymphocytes in mice. Proc Natl Acad Sci U S A (1972) 2.35
Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. N Engl J Med (1970) 2.33
Isolation of human T and B lymphocytes by rosette formation with 2-aminoethylisothiquronium bromide (AET) -treated sheep red blood cells with monkey red blood cells. J Immunol Methods (1976) 2.30
Characterization and isolation of specific renal tubular epithelial antigens. J Immunol (1967) 2.25
Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism. J Exp Med (1974) 2.22
Antigen-induced translocation of PKC-theta to membrane rafts is required for T cell activation. Nat Immunol (2001) 2.18
Effect of prostaglandin E 1 on leukocyte migration. Nat New Biol (1971) 2.16
Neoadjuvant hormonal ablative therapy before radical prostatectomy: a review. Is it indicated? J Urol (2000) 2.16
The effect of induced chronic viral infections on the immunologic diseases of New Zealand mice. J Exp Med (1970) 2.16
Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype. J Exp Med (1983) 2.15
NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta. Proc Natl Acad Sci U S A (2000) 2.13
Immunopathogenicity and oncogenicity of murine leukemia viruses. I. Induction of immunologic disease and lymphoma in (BALB-c times NZB)F1 mice by Scripps leukemia virus. J Exp Med (1974) 2.12
Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol (2001) 2.12
Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci U S A (1994) 2.12
Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation. Science (1993) 2.10
Immunohistochemical study of allergic encephalomyelitis. Am J Pathol (1968) 2.10
Pathogenesis of the slow disease of the central nervous system associated with WM 1504 E virus. I. Relationship of strain susceptibility and replication to disease. Am J Pathol (1977) 2.08
Influence of thymic genotype on the systemic lupus erythematosus-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice. J Exp Med (1981) 2.07
Diagnosis of immunopathologic renal disease. Kidney Int (1974) 2.07
Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice. J Exp Med (1980) 2.07
Induction of murine autoimmune disease by chronic polyclonal B cell activation. J Exp Med (1983) 2.06